NZ553175A - Antimicrobial peptides derived from CAP18 for treating bacterial or fungal infections - Google Patents

Antimicrobial peptides derived from CAP18 for treating bacterial or fungal infections

Info

Publication number
NZ553175A
NZ553175A NZ553175A NZ55317505A NZ553175A NZ 553175 A NZ553175 A NZ 553175A NZ 553175 A NZ553175 A NZ 553175A NZ 55317505 A NZ55317505 A NZ 55317505A NZ 553175 A NZ553175 A NZ 553175A
Authority
NZ
New Zealand
Prior art keywords
use according
terminal part
compounds
bacterial
infection
Prior art date
Application number
NZ553175A
Other languages
English (en)
Inventor
Johannes Jakobus Grote
Jan Wouter Drijfhout
Maartje Johanna Nell
Marcel Jan Vonk
Guido Vincent Bloemberg
Pieter Sicco Hiemstra
Original Assignee
Octoplus Sciences Bv
Academisch Ziekenhuis Leiden
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Octoplus Sciences Bv, Academisch Ziekenhuis Leiden filed Critical Octoplus Sciences Bv
Publication of NZ553175A publication Critical patent/NZ553175A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/04Nitro compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
NZ553175A 2004-07-28 2005-07-26 Antimicrobial peptides derived from CAP18 for treating bacterial or fungal infections NZ553175A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04077175A EP1621205A1 (en) 2004-07-28 2004-07-28 Antimicrobial peptides derived from CAP18
PCT/NL2005/000545 WO2006011792A2 (en) 2004-07-28 2005-07-26 Antimicrobial peptides derived from cap18

Publications (1)

Publication Number Publication Date
NZ553175A true NZ553175A (en) 2009-10-30

Family

ID=34928414

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ553175A NZ553175A (en) 2004-07-28 2005-07-26 Antimicrobial peptides derived from CAP18 for treating bacterial or fungal infections

Country Status (11)

Country Link
US (2) US7803756B2 (https=)
EP (3) EP1621205A1 (https=)
JP (1) JP2008508265A (https=)
KR (1) KR20070050941A (https=)
CN (1) CN101018563A (https=)
AU (1) AU2005267651B2 (https=)
BR (1) BRPI0513856A (https=)
CA (1) CA2574959A1 (https=)
NZ (1) NZ553175A (https=)
RU (1) RU2392962C2 (https=)
WO (1) WO2006011792A2 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1621205A1 (en) * 2004-07-28 2006-02-01 OctoPlus Technologies B.V. Antimicrobial peptides derived from CAP18
JP5762683B2 (ja) 2006-12-01 2015-08-12 ラクレード,インコーポレーテッド 耳内のバイオフィルムを溶解するための加水分解酵素及び酸化酵素の使用
EP2175865A4 (en) 2007-07-25 2012-01-11 Biolex Therapeutics Inc INTERFERON DRUG PRODUCTS WITH CONTROLLED RELEASE AND TREATMENT OF HCV INFECTIONS THEREWITH
US20110039763A1 (en) 2009-01-06 2011-02-17 C3 Jian, Inc. Targeted antimicrobial moieties
US20130079382A1 (en) 2009-10-12 2013-03-28 Larry J. Smith Methods and Compositions for Modulating Gene Expression Using Oligonucleotide Based Drugs Administered in vivo or in vitro
RU2434880C1 (ru) * 2010-07-21 2011-11-27 Общество С Ограниченной Ответственностью "Биохарт" Полипептид, имеющий антибактериальную активность и пригодный для получения лекарственных средств для лечения бактериальных инфекций человека
BR112014027818B1 (pt) * 2012-05-09 2023-03-28 Contrafect Corporation Usos de composições compreendendo polipeptídeo de lisina para prevenção, ruptura ou tratamento de um biofilme bacteriano
CN105555290B (zh) * 2013-05-10 2021-11-09 莱顿大学学术医院以Lumc的名义运作 抗微生物肽
US9387189B2 (en) 2013-05-22 2016-07-12 Professional Compounding Centers Of America (Pcca) Antibiotic composition comprising a chemotactic agent and a nutrient dispersion
WO2015075406A1 (en) * 2013-11-19 2015-05-28 Lipopeptide Ab New treatment of chronic ulcers
PL3087092T3 (pl) 2013-12-12 2018-12-31 Academisch Ziekenhuis Leiden H.O.D.N. Lumc Peptyd przeciwdrobnoustrojowy i jego zastosowania
WO2015164289A1 (en) * 2014-04-21 2015-10-29 Cidara Therapeutics, Inc. Compositions and methods for the treatment of fungal infections
US20250034218A1 (en) * 2021-09-21 2025-01-30 Biomedit, Llc Antimicrobial peptides

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4037525B2 (ja) * 1998-03-25 2008-01-23 生化学工業株式会社 新規抗菌性ペプチド
ATE435870T1 (de) * 2003-01-28 2009-07-15 Academisch Ziekenhuis Leiden Aus ll-37 abgeleiteten peptidinhibitoren von toxinen
WO2005040192A2 (en) * 2003-10-21 2005-05-06 The Regents Of The University Of California Human cathelicidin antimicrobial peptides
EP1621205A1 (en) * 2004-07-28 2006-02-01 OctoPlus Technologies B.V. Antimicrobial peptides derived from CAP18

Also Published As

Publication number Publication date
WO2006011792A3 (en) 2006-09-14
KR20070050941A (ko) 2007-05-16
BRPI0513856A (pt) 2008-05-20
CA2574959A1 (en) 2006-02-02
EP1621205A1 (en) 2006-02-01
WO2006011792A2 (en) 2006-02-02
AU2005267651B2 (en) 2010-05-27
JP2008508265A (ja) 2008-03-21
EP1784206A2 (en) 2007-05-16
RU2392962C2 (ru) 2010-06-27
EP2221061A1 (en) 2010-08-25
US20110053835A1 (en) 2011-03-03
US7803756B2 (en) 2010-09-28
AU2005267651A1 (en) 2006-02-02
US20080249022A1 (en) 2008-10-09
RU2007107390A (ru) 2008-09-10
CN101018563A (zh) 2007-08-15

Similar Documents

Publication Publication Date Title
US20110053835A1 (en) Antimicrobial peptides derived from cap18
AU2004207118B2 (en) Peptide inhibitors of toxins derived from LL-37
US8466102B2 (en) Antimicrobial cationic peptides and formulations thereof
JP2002544759A (ja) カチオン性ペプチド単独、または抗生物質と組み合わせて用いて感染を処置するための組成物および方法
US11266712B2 (en) Antimicrobial peptides and methods of using the same
US20210324359A1 (en) Use of gram-negative lysin-antimicrobial peptide (amp) polypeptide constructs in treating endocarditis
CN101878226A (zh) 精氨酸取代的新型合成肽及其应用
HK1102693A (en) Antimicrobial peptides derived from cap18
JP6506317B2 (ja) ペプチドおよびその使用
CA2360381A1 (en) Methods for treating cystic fibrosis
HK1088613B (en) Peptide inhibitors of toxins derived from ll-37
AU2018445889B2 (en) Antimicrobial peptides and methods of using the same

Legal Events

Date Code Title Description
ASS Change of ownership

Owner name: ACADEMISCH ZIEKENHUIS LEIDEN, NL

Free format text: OLD OWNER(S): JOHANNES JAKOBUS GROTE; JAN WOUTER DRIJFHOUT; PIETER SICCO HIEMSTRA; MAARTJE JOHANNA NELL; MARCEL JAN VONK; GUIDO VINCENT BLOEMBERG

Owner name: OCTOPLUS SCIENCES B.V., NL

Free format text: OLD OWNER(S): JOHANNES JAKOBUS GROTE; JAN WOUTER DRIJFHOUT; PIETER SICCO HIEMSTRA; MAARTJE JOHANNA NELL; MARCEL JAN VONK; GUIDO VINCENT BLOEMBERG

S883 Correction of error according to section 88(3) (mistake in register caused on part of patentee or applicant)

Free format text: THE ORIGINAL APPLICANT (71) WERE THE INVENTORS (72) WHO SUBSEQUENTLY ASSIGNED THE PATENT APPLICATION TO THE APPLICANT

PSEA Patent sealed